The Rights Issue Committee of #eikolifesciences approved converting 12,71,303 partly paid-up shares into fully paid-up shares and forfeiting 1,39,591 shares due to non-payment. Applications for necessary corporate actions will be made to NSDL and CDS
#eikolifesciences